Citation: Sjov. Vanzanten et Nj. Talley, SHOULD ANTIBIOTIC-TREATMENT OF HELICOBACTER-POSITIVE PATIENTS WITH NONULCER DYSPEPSIA NOW BE RECOMMENDED, European journal of gastroenterology & hepatology, 10(5), 1998, pp. 367-370
Authors:
GOODWIN A
KERSULYTE D
SISSON G
VANZANTEN SJOV
BERG DE
HOFFMAN PS
Citation: A. Goodwin et al., METRONIDAZOLE RESISTANCE IN HELICOBACTER-PYLORI IS DUE TO NULL MUTATIONS IN A GENE (RDXA) THAT ENCODES AN OXYGEN-INSENSITIVE NADPH NITROREDUCTASE, Molecular microbiology, 28(2), 1998, pp. 383-393
Authors:
YEUNG PKF
LITTLE R
JIANG YQ
BUCKLEY SJ
POLLAK PT
KAPOOR H
VANZANTEN SJOV
Citation: Pkf. Yeung et al., A SIMPLE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ASSAY FOR SIMULTANEOUS DETERMINATION OF OMEPRAZOLE AND METRONIDAZOLE IN HUMAN PLASMA AND GASTRIC FLUID, Journal of pharmaceutical and biomedical analysis, 17(8), 1998, pp. 1393-1398
Authors:
BARDHAN KD
BAYERDORFFER E
DELCHIER JP
HELLBLOM M
MEGRAUD F
STUBBEROD A
VANZANTEN SJOV
LIND T
BURMAN CF
GROMARK PO
Citation: Kd. Bardhan et al., H. PYLORI (HP) ERADICATION WITH OMEPRAZOLE (O), METRONIDAZOLE (M) ANDAMOXICILLIN (A) - THE IMPACT OF DRUG DOSING AND RESISTANCE ON EFFICACY - THE HOMER STORY, Gut, 42, 1998, pp. 290-290
Authors:
BARDHAN KD
BAYERDORFFER E
DELCHIER JP
HELLBLOM M
MEGRAUD F
STUBBEROD A
VANZANTEN SJOV
LIND T
BURMAN CF
GROMARK PO
Citation: Kd. Bardhan et al., HELICOBACTER-PYLORI (HP) ERADICATION WITH OMEPRAZOLE (O), METRONIDAZOLE (M) AND AMOXICILLIN (A) - THE IMPACT OF DRUG DOSING AND RESISTANCE ON EFFICACY - THE HOMER STORY, Gastroenterology, 114(4), 1998, pp. 264-264
Citation: Gs. Sandha et al., A SYSTEMATIC OVERVIEW OF THE USE OF DIARY CARDS, QUALITY-OF-LIFE QUESTIONNAIRES AND PSYCHOMETRIC TESTS IN THE TREATMENT TRIALS OF HELICOBACTER-PYLORI POSITIVE AND NEGATIVE NONULCER DYSPEPSIA, Gastroenterology, 114(4), 1998, pp. 1131-1131
Authors:
BEST LM
HALDANE DJM
BURFORD N
VANZANTEN SJOV
Citation: Lm. Best et al., HELICOBACTER-PYLORI SUSCEPTIBILITY TO ANTIMICROBIAL COMPOUNDS MEASURED BY FLOW-CYTOMETRY, Gastroenterology, 114(4), 1998, pp. 3816-3816
Authors:
CHIBA N
LAHAIE R
FEDORAK RN
BAILEY R
VANZANTEN SJOV
BERNUCCI B
Citation: N. Chiba et al., HELICOBACTER-PYLORI AND PEPTIC-ULCER DISEASE - CURRENT EVIDENCE FOR MANAGEMENT STRATEGIES, Canadian family physician, 44, 1998, pp. 1481-1488
Authors:
BEST LM
HALDANE DJM
BEZANSON GS
VANZANTEN SJOV
Citation: Lm. Best et al., HELICOBACTER-PYLORI - PRIMARY SUSCEPTIBILITY TO CLARITHROMYCIN IN-VITRO IN NOVA-SCOTIA, Canadian journal of gastroenterology, 11(4), 1997, pp. 298-300
Citation: Sjov. Vanzanten et al., HELICOBACTER-PYLORI - CORRECTIONS AND COMMENTS - RESPONSE, CMAJ. Canadian Medical Association journal, 157(9), 1997, pp. 1199-1199
Citation: Sjov. Vanzanten et al., HELICOBACTER-PYLORI - NEW DEVELOPMENTS AND TREATMENTS, CMAJ. Canadian Medical Association journal, 156(11), 1997, pp. 1565-1574
Citation: Sjov. Vanzanten, THE ROLE OF HELICOBACTER-PYLORI INFECTION IN NONULCER DYSPEPSIA, Alimentary pharmacology & therapeutics, 11, 1997, pp. 63-69
Authors:
LIND T
MEGRAUD F
BARDHAN KD
BAYERDORFFER E
HELLBLOM M
OMORAIN C
SPILLER RC
UNGE P
VANZANTEN SJOV
WRANGSTADH M
ZEIJLON L
CEDERBERG C
Citation: T. Lind et al., THE MACH2 STUDY - ANTIMICROBIAL RESISTANCE IN HELICOBACTER-PYLORI THERAPY - THE IMPACT OF OMEPRAZOLE, Gut, 41, 1997, pp. 89-89
Authors:
MALFERTHEINER P
BAYERDORFFER E
DIETE U
GIL J
LIND T
MISIUNA P
OMORAIN C
SIPPONEN P
SPILLER RC
STASIEWICZ J
TREICHEL HC
UJSZASZY L
UNGE P
VANZANTEN SJOV
ZEIJLON L
Citation: P. Malfertheiner et al., THE GU-MACH STUDY - ERADICATION OF HELICOBACTER-PYLORI, ULCER HEALINGAND RELAPSE IN GASTRIC-ULCER PATIENTS - OMEPRAZOLE AND CLARITHROMYCININ COMBINATION WITH EITHER AMOXICILLIN OR METRONIDAZOLE, Gut, 41, 1997, pp. 97-97
Authors:
VANZANTEN SJOV
BRADETTE M
FARLEY A
BAYERDORFFER E
LIND T
OMORAIN C
SIPPONEN P
SPILLER RC
UNGE P
SINCLAIR P
WRANGSTADH M
ZEIJLON L
Citation: Sjov. Vanzanten et al., THE DU-MACH STUDY - ERADICATION OF HELICOBACTER-PYLORI, ULCER HEALINGAND RELAPSE IN DUODENAL-ULCER PATIENTS - OMEPRAZOLE AND CLARITHROMYCIN IN COMBINATION WITH EITHER AMOXICILLIN OR METRONIDAZOLE, Gut, 41, 1997, pp. 103-103
Authors:
VANZANTEN SJOV
OROURKE J
LARSSON H
MELLGARD B
LEE A
Citation: Sjov. Vanzanten et al., UREASE AND LOCAL ACID - CRITICAL FACTORS IN THE BEHAVIOR OF HELICOBACTER SPECIES IN THE GASTRIC-MUCOSA, Gut, 41, 1997, pp. 118-119
Citation: Sjov. Vanzanten, BLEEDING ULCERS, INTERACTION BETWEEN NSAIDS AND HELICOBACTER-PYLORI INFECTION, AND NONULCER DYSPEPSIA, Gastroenterology, 113(6), 1997, pp. 90-92
Citation: Sjov. Vanzanten et Cw. Mccormick, ANTINUCLEAR ANTIBODY-POSITIVE TICLOPIDINE-INDUCED HEPATITIS, Canadian journal of gastroenterology, 10(4), 1996, pp. 231-232
Authors:
HOFFMAN PS
GOODWIN A
JOHNSEN J
MAGEE K
VELDHUYZEN SJO
VANZANTEN SJOV
Citation: Ps. Hoffman et al., METABOLIC-ACTIVITIES OF METRONIDAZOLE-SENSITIVE AND METRONIDAZOLE-RESISTANT STRAINS OF HELICOBACTER-PYLORI - REPRESSION OF PYRUVATE OXIDOREDUCTASE AND EXPRESSION OF ISOCITRATE LYASE ACTIVITY CORRELATE WITH RESISTANCE, Journal of bacteriology, 178(16), 1996, pp. 4822-4829
Authors:
VANZANTEN SJOV
CLEARY C
TALLEY NJ
PETERSON TC
NYREN O
BRADLEY LA
VERLINDEN M
TYTGAT GNJ
Citation: Sjov. Vanzanten et al., DRUG-TREATMENT OF FUNCTIONAL DYSPEPSIA - A SYSTEMATIC ANALYSIS OF TRIAL METHODOLOGY WITH RECOMMENDATIONS FOR DESIGN OF FUTURE TRIALS, The American journal of gastroenterology, 91(4), 1996, pp. 660-673